Cargando…

Expression of the GLI family genes is associated with tumor progression in advanced lung adenocarcinoma

BACKGROUND: The hedgehog (Hh) signaling pathway is aberrantly activated in various cancers. Expression of the GLI family of genes, which encode for transcriptional factors of the Hh pathway, has not been fully assessed in clinical samples of advanced lung adenocarcinoma. In this study, we retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishikawa, Masashi, Sonobe, Makoto, Imamura, Naoto, Sowa, Terumasa, Shikuma, Kei, Date, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4249769/
https://www.ncbi.nlm.nih.gov/pubmed/25103784
http://dx.doi.org/10.1186/1477-7819-12-253
_version_ 1782346885641535488
author Ishikawa, Masashi
Sonobe, Makoto
Imamura, Naoto
Sowa, Terumasa
Shikuma, Kei
Date, Hiroshi
author_facet Ishikawa, Masashi
Sonobe, Makoto
Imamura, Naoto
Sowa, Terumasa
Shikuma, Kei
Date, Hiroshi
author_sort Ishikawa, Masashi
collection PubMed
description BACKGROUND: The hedgehog (Hh) signaling pathway is aberrantly activated in various cancers. Expression of the GLI family of genes, which encode for transcriptional factors of the Hh pathway, has not been fully assessed in clinical samples of advanced lung adenocarcinoma. In this study, we retrospectively evaluated the expression of the GLI family of genes in advanced stage lung adenocarcinoma samples and determined their relation to patient survival. METHODS: The levels of GLI1, GLI2, and GLI3 mRNA expression were measured by quantitative real-time polymerase chain reaction in surgically obtained tissue samples from stage II-IV lung adenocarcinoma patients (n = 102). Pairwise comparisons between all three GLI mRNA expression were performed, and after dichotomizing the patients into low and high expression groups according to each GLI mRNA expression level, survival curves were calculated and multivariate analyses were conducted. RESULTS: Significant positive correlation was found between GLI1 and GLI3 mRNA expression (P <0.001). Tumors with higher expression (upper 15%) of GLI1 or GLI3 mRNA were associated with poor survival in stage II-IV (5-year overall survival rates: GLI1 mRNA low, 41.7% vs. high, 20.0%, P = 0.0074; GLI3 mRNA low, 43.1% vs. high, 13.3%, P = 0.0062) and stage III-IV (5-year overall survival rates: GLI1 mRNA low, 34.0% vs. high, 0%, P = 0.0012; GLI3 mRNA low, 33.4% vs. high, 7.7%, P = 0.057) lung adenocarcinoma patients. GLI2 mRNA expression did not appear to have great clinical significance. Multivariate analysis revealed higher GLI1 mRNA expression as an independent factor for unfavorable patient survival (P = 0.0030, hazard ratio = 3.1, 95% confidence interval = 1.5-6.2), as well as tumor differentiation and stage. CONCLUSIONS: Expression of GLI1 and GLI3 mRNA was strongly correlated, and their overexpression, especially that of GLI1, was found to be predictive of aggressive tumor behavior. This study indicates that the Hh pathway may be a key oncogenic signaling network in tumor pathogenesis and, thus, a potential therapeutic target in advanced lung adenocarcinoma.
format Online
Article
Text
id pubmed-4249769
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42497692014-12-02 Expression of the GLI family genes is associated with tumor progression in advanced lung adenocarcinoma Ishikawa, Masashi Sonobe, Makoto Imamura, Naoto Sowa, Terumasa Shikuma, Kei Date, Hiroshi World J Surg Oncol Research BACKGROUND: The hedgehog (Hh) signaling pathway is aberrantly activated in various cancers. Expression of the GLI family of genes, which encode for transcriptional factors of the Hh pathway, has not been fully assessed in clinical samples of advanced lung adenocarcinoma. In this study, we retrospectively evaluated the expression of the GLI family of genes in advanced stage lung adenocarcinoma samples and determined their relation to patient survival. METHODS: The levels of GLI1, GLI2, and GLI3 mRNA expression were measured by quantitative real-time polymerase chain reaction in surgically obtained tissue samples from stage II-IV lung adenocarcinoma patients (n = 102). Pairwise comparisons between all three GLI mRNA expression were performed, and after dichotomizing the patients into low and high expression groups according to each GLI mRNA expression level, survival curves were calculated and multivariate analyses were conducted. RESULTS: Significant positive correlation was found between GLI1 and GLI3 mRNA expression (P <0.001). Tumors with higher expression (upper 15%) of GLI1 or GLI3 mRNA were associated with poor survival in stage II-IV (5-year overall survival rates: GLI1 mRNA low, 41.7% vs. high, 20.0%, P = 0.0074; GLI3 mRNA low, 43.1% vs. high, 13.3%, P = 0.0062) and stage III-IV (5-year overall survival rates: GLI1 mRNA low, 34.0% vs. high, 0%, P = 0.0012; GLI3 mRNA low, 33.4% vs. high, 7.7%, P = 0.057) lung adenocarcinoma patients. GLI2 mRNA expression did not appear to have great clinical significance. Multivariate analysis revealed higher GLI1 mRNA expression as an independent factor for unfavorable patient survival (P = 0.0030, hazard ratio = 3.1, 95% confidence interval = 1.5-6.2), as well as tumor differentiation and stage. CONCLUSIONS: Expression of GLI1 and GLI3 mRNA was strongly correlated, and their overexpression, especially that of GLI1, was found to be predictive of aggressive tumor behavior. This study indicates that the Hh pathway may be a key oncogenic signaling network in tumor pathogenesis and, thus, a potential therapeutic target in advanced lung adenocarcinoma. BioMed Central 2014-08-08 /pmc/articles/PMC4249769/ /pubmed/25103784 http://dx.doi.org/10.1186/1477-7819-12-253 Text en © Ishikawa et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Research
Ishikawa, Masashi
Sonobe, Makoto
Imamura, Naoto
Sowa, Terumasa
Shikuma, Kei
Date, Hiroshi
Expression of the GLI family genes is associated with tumor progression in advanced lung adenocarcinoma
title Expression of the GLI family genes is associated with tumor progression in advanced lung adenocarcinoma
title_full Expression of the GLI family genes is associated with tumor progression in advanced lung adenocarcinoma
title_fullStr Expression of the GLI family genes is associated with tumor progression in advanced lung adenocarcinoma
title_full_unstemmed Expression of the GLI family genes is associated with tumor progression in advanced lung adenocarcinoma
title_short Expression of the GLI family genes is associated with tumor progression in advanced lung adenocarcinoma
title_sort expression of the gli family genes is associated with tumor progression in advanced lung adenocarcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4249769/
https://www.ncbi.nlm.nih.gov/pubmed/25103784
http://dx.doi.org/10.1186/1477-7819-12-253
work_keys_str_mv AT ishikawamasashi expressionoftheglifamilygenesisassociatedwithtumorprogressioninadvancedlungadenocarcinoma
AT sonobemakoto expressionoftheglifamilygenesisassociatedwithtumorprogressioninadvancedlungadenocarcinoma
AT imamuranaoto expressionoftheglifamilygenesisassociatedwithtumorprogressioninadvancedlungadenocarcinoma
AT sowaterumasa expressionoftheglifamilygenesisassociatedwithtumorprogressioninadvancedlungadenocarcinoma
AT shikumakei expressionoftheglifamilygenesisassociatedwithtumorprogressioninadvancedlungadenocarcinoma
AT datehiroshi expressionoftheglifamilygenesisassociatedwithtumorprogressioninadvancedlungadenocarcinoma